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The emergence of virulent avian influenza viruses in poultry is unpredictable. To gain insight into the mechanism for this 
event, we sought o identify the molecular changes in virulent mutants that occur during replication in 14-day-old embryonated 
chicken eggs. After three passages in 14-day-old eggs, avirulent H5 viruses with the K/R-K-K/T-R sequence at the hemaggluti- 
nin (HA) cleavage site became virulent in chickens, concomitantly acquiring high HA cleavability, whereas those with the 
R-E-T-R sequence did not. None of the test viruses converted to a virulent phenotype when passaged in lO-day-old eggs. 
Nucleotide sequence analysis indicated that the virulent mutants either lost a glycosylation site near the HA cleavage site 
or acquired an additional arginine at the latter. Avirulent viruses that became virulent after passage in older eggs included 
an H5N2 avian strain with the R-K-T-R sequence that was isolated in 1993, indicating that viruses with this sequence motif, 
which are currently circulating in bird populations, should be considered potentially virulent. Failure to generate virulent 
mutants from viruses with R-E-T-R at the HA cleavage site underscores the pathogenic heterogeneity among avian influenza 
viruses. © 1995 Academic Press, Inc. 
Although polygenic in origin, the virulence of avian 
influenza viruses correlates well with the cleavability of 
the hemagglutinin (HA) molecule (1, 2). In April 1983, a 
mild respiratory disease caused by an H5N2 influenza 
virus occurred in chickens in Pennsylvania. Six months 
later the virus became highly virulent (3). Nucleotide se- 
quence analysis suggested that the critical molecular 
change was a point mutation resulting in loss of a glyco- 
sylation site at Asn-11 in the HA; the pathogenic contribu- 
tions of other changes distinguishing the HA of the 
virulent virus from that of avirulent viruses (4) remain 
uncertain. 
What was the selective pressure that led to the appear- 
ance of the virulent influenza virus in October of 1983? 
The answer may provide important clues to the prediction 
and prevention of avian influenza outbreaks. Ohuchi et 
al. (5) described several virulent mutants of an avirulent 
0hicken/Pennsylvania/83 virus that were selected 
through successive passages in trypsin-free chicken em- 
bryo fibroblast (CEF) culture. These mutants had in- 
creased numbers of basic amino acids at the HA cleav- 
age site without alteration of a glycosylation site at Asn- 
11, suggesting a difference between selective pressures 
operating in CEF cultures and nature. Brugh and Beck 
(6) recently showed that virulent influenza virus variants 
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can be readily selected in 14-day-old, but not 10-day- 
old, embryonated chicken eggs inoculated with avirulent 
viruses isolated during the 1983 outbreak. When they 
inoculated 14-day-old eggs with the avirulent viruses, 
approximately 10% of the eggs contained viruses with 
the ability to form plaques in trypsin-free CEF and to kill 
chickens. However, the molecular basis for this change 
in phenotype is unknown. 
We recently reported the emergence in the eastern 
United States, of avirulent H5N2 viruses that represent 
a different phylogenetic lineage from the 1983 strain (7). 
Their HA cleavage site sequence (R-K-T-R) resembled 
that of a recently isolated virulent virus (R-K-R-K-T-R; 8), 
although it lacks two basic amino acids at the fifth and 
sixth positions from the carboxyl terminus of the HA1. In 
the study reported here, we sought to identify the molecu- 
lar changes responsible for the generation of virulent 
mutants during replication in 14-day-old eggs and to as- 
sess the potential for an avirulent H5N2 1993 isolate to 
become virulent through passaging in a system of this 
type. 
We used five avirulent H5 viruses in this study. A/ 
chicken/Pennsylvania/I/83 (H5N2) [0P/1/83] (4) and A/ 
turkey/Minnesota/1550/81 (H5N2) [-I-M81] were obtained 
from the repository at St. Jude Children's Research 
Hospital. A/environment/Pennsylvania/937302/93 (H5N2) 
[EP93] was isolated from a swab of the cage housing 
chickens infected with the 1993 avirulent HSN2 virus (7). 
The R(MO-2) and R(MO-4) avirulent mutants of A/turkey/ 
Ontario/7732/66 (H5N9), which carry R-K-K-R and R-E-T- 
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TABLE 1 
PARENT H5 AVIAN INFLUENZA A VIRUSES AND MUTANTS SELECTED IN 14-DAY-OLD EGGS 
Potential 
glycesylation Potential 
site glycosylation at Cleavage site HA cleavability 
Virus (Abbreviation) sequence a Asn-~i 1 sequence a in CEF b 
11 
A/chicken/Pennsylvania/I/83 (H5N£) 
Parent [0P/1/83] aat  tca  aca +c 8_ag aaa_ aa.g aga - 
N S T K K K R 
Mutant [CP/I/83-M1] aa_a tca  aca  - aag  aaa  aag  aga  + 
_K S T K K K R 
[CP/1/83-M2] aat  tca  aaa  - aag  aaa  aag  aga  + 
N S _K K K K R 
A/chicken/Pennsylvania/1370/83 (HSN2) 
[CP/1370/83] aat  tca  aaa  - aag  aa& aag  aga  + 
N S K K K K R 
A/environment/Pennsylvania/937302/93 (HSN2) 
Parent [EP93] aat  tca  aca  + aga  aaa  aca  aga  - 
N S T R K T R 
Mutant [EP93-M1] aat  tca  a~a -- aga  aaa  aca  aga  + 
N S _K R K T R 
A/turkey/Ontario/7732/66(H5Ng) avirulent R(MO-2) 
Parent [R(MO-2)] aat  tca  aca  + aga  aaa  aaa  aga  - 
N S T R K K R 
Mutant [R(MO-2)-MI] aat  tca  aca  + ~ aga  aaa  aaa  aga  " + 
N S T _R R K K R 
[R(MO-2)-M2] aat  tca  aca  + ~ aga  aaa  aaa  aga  + 
N S T R_ R I< K R 
a Altered or inserted nucleotides and amino acids are underlined. PCR amplification of HA cDNA of each virus was performed with two primer 
sets, H5-19 and HS-1262R (7) or HS(TOH)-951, 5'-ACAATGTTCATCCCCTIACCATI-GG-3' and H5-1735R, 5 ' -GTG~AA(C/T)TA(C/A)AATCTG(A/  
G)ACT(C/A)A-3'. PCR products were sequenced with Taq polymerase as described earlier (7). The sequence of the HA gene of 0P/1/83 was 
identical to that reported by Ohuchi et aL (5). The nucleotide sequence of the HA gene of CP/1370/83 contained four changes at positions 38 
(C -~ A), 207 (G -~ T), 367 (G ~ A), and 1501 (A ~ G), as compared with the CP/t/83 sequence, resulting in amino acid changes Thr ~ Lys, 
GIu ~ Asp, Ala ~ Thr, and Val ~ lie, respectively, as previously reported (4). The HA1 sequence of EP93 was identical to that of A/chicken/ 
Pennsylvania/13609/93 (H5N2) except for a nucleotide change at a position 148 (C ~ T; Leu ~ Phe) (7). The HA sequences of R(MO-2) were 
described earlier (9). 
b Determined by RIP analysis (Fig. 1). 
° Demonstrated by direct amino acid sequencing (22). 
R sequences, respectively, at the HA cleavage site, were 
generated previously by reverse genetics (9). The 1983 
virulent isolate, A/chicken/Pennsylvania/1370/83 (HSN2) 
[0P/1370/83] (4) served as a control. Mutant viruses are 
distinguished from the parent strains by an "M" suffix, 
followed by 1 or 2 depending on the experiment in which 
the mutant was generated (Table 1). Only one experiment 
for 14-day-old egg passage was conducted with EP93. 
Experiments with infectious viruses were performed in a 
BL-3 containment laboratory at St. Jude Children's Re- 
search Hospital, approved for such use by the U.S. De- 
partment of Agriculture. 
Biologically uncloned virus stocks of CP/1/83, EP93, 
and TM81 or virus stocks of R(MO-2) and R(MO-4), which 
were biologically cloned by egg-limiting dilutions, were 
inoculated (106 medial egg infectious doses)into the al- 
lantoic cavity of either 14- or 10-day-old embryonated 
chicken eggs. Allantoic fluids containing viruses were 
harvested from eggs at 5 days postinoculation. This pro- 
cedure was repeated two more times. After three pas- 
sages in 14-day-old eggs, the 0P/1/83, EP93, and R(MO- 
2) showed an 80% increase (from 20% to 100%)in lethal- 
ity. TM81 and R(MO-4) remained nonlethal. Experiments 
were repeated with 0P/1/83 and R(MO-2), and the results 
were reproducible. 
To determine the correlation of these findings with 
HA cleavability, we tested the plaque-forming ability of 
viruses in trypsin-free CEF culture as an indication of HA 
cleavage by intracellular proteases. 0P/1/83, EP93, and 
R(MO-2) produced plaques after passage in older eggs 
in contrast to TM81, R(MO-4), and the five original parent 
strains. None of the viruses produced plaques in trypsin- 
free CEF culture after three passages in 10-day-old eggs. 
Thus, older eggs appear to promote the selection of mu- 
tant viruses. The results also indicate differing capacities 
among virus strains to become a plaque-forming virus in 
trypsin-free CEF. 
The acquisition of plaque-forming ability in trypsin-free 
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Re. 1. HA cleavability of H5 avirulent viruses and their mutants Jn 
0EF culture. Viruses were inoculated in CEF culture and radiolabeled 
in the presence of TranS~S label (ION) for 20 hr. Progeny viruses in the 
culture supernatant were purified through 30% sucrose in STE buffer 
(20 mM Tris-HCl, pH 7.5; 150 mM NaCI; and 1 mM EDTA) and lysed 
for radioimmunoprecipitation analysis without (A) or with (B) trypsin- 
treatment (2.5 ffg/ml 15 rain 37 °) as described earlier (7). 
@EF culture suggested that the CP/1/83, EP93, and 
R(MO-2) viruses had undergone changes in HA cleavabil- 
ity. When examined by radioimmunoprecipitation (RIP) 
analysis (7), the HAs of all three mutants were indeed 
found to be. cleaved by intracellular proteases (Fig. 1A; 
without trypsin treatment). The electrophoretic mobilities 
of the HA1 of the CP/1/83-M1 and -M2 mutants were 
faster than that of the parent virus (CP/1/83), but similar 
to that of the 1983 virulent isolate (CP/1370/83), whereas 
the HA2s of all the viruses had similar mobilities (Fig. 
1B; with trypsin treatment). The electrophoretic mobility 
change seen in the HA1 of the mutant CP/1/83 was also 
apparent in EP93-M1. By contrast, neither the HA1 nor 
the HA2 of R(MO-2)-M1 or -M2 showed electrophoretic 
mobility changes relative to the parent virus. 
To identify the mutations of viruses selected in older 
eggs, we sequenced the HA genes of both the parent 
and mutant strains (Table 1). In previous studies, a single 
mutation at nucleotide position 38 (C --* A; Thr-13 -* Lys) 
was responsible for alteration of the HA cleavability of 
the 1983 Pennsylvania virus (4). This change abolished a 
potential glycosylation signal sequence (Asn-X-Thr/Ser), 
resulting in the loss of glycosylation at Asn-11. The muta- 
tion in CP/1/83-M2 was identical to that in CP/1370/83, 
but CP/1/83-M1 contained a different mutation= Asm11 
was replaced by Lys (T-33 --* A). Thus, the glycosylation 
site at Asn-11 in the parent 0P/1/83 was abolished in 
the HAs of both mutants. No mutation was found near 
the cleavage site sequence (K-K-K-R) in either of these 
mutants. No other HA mutations were observed in CP/ 
1/83-M1, but two additional mutations were found at pc- 
sitions 280 (G ~ A; Asp ~ Ash) and 941 (C ~ T; Thr --+ 
lie) in CP/1/83-M2. These findings indicate that the in- 
creased electrophoretic mobilities of both mutant HAls 
were due to a loss of glycosylation resulting in increased 
HA cleavability. Thus, the selection for virulent mutants 
in older eggs differs from thatin trypsin-free CEF (5) but 
appears analogous to that giving rise to the naturally 
isolated virulent 0P/1370/83 virus. 
The C-38--*A mutation abolishing a potential glycosyl- 
ation site at Asn-11 and two silent mutations (T-147 -e 
C; G-780 --* A) were found in the HA gene of EP93-M1; 
however, the cleavage site sequence of the mutant (R- 
K-T-R) was identical to that of the parent virus (Table 1). 
Thus, an R-K-T-R sequence at the cleavage site is suffi- 
cient for HA cleavage by intracellular preteases in CEF 
in the absence of a nearby oligosaccharide side chain. 
In R(MO-2) mutants, an arginine insertion was found in 
the cleavage site but no mutation was detected in the 
Asn- l l  glycosylation site (Table 1). Additional HA muta- 
tions were observed at position 710 (G -~ A; Gin ~ Lys) 
in R(MO-2)-M1 and two other mutations at positions 641 
(A --* G; Arg -~ Gly) and 947 (T -~ C; Phe -~ Leu) in R(MO- 
2)-M2. From these analyses, it appears that two distinct 
types of mutations - - loss  of the glycosylation site at Asn- 
11 and insertion of an arginine at the HA cleavage site - -  
are responsible for the alterations in HA cleavability 
characteristic of viruses grown in older eggs. 
The virulence of two mutants (CP/1/83-M1 and EP93- 
M1) with high HA cleavability due to selection in older 
eggs, as well as a natural isolate (CP/1370/83), was as- 
sessed in chickens. Unlike the CP/1/83 parent virus, CP/ 
1/83-M1 produced 100% mortality regardless of the inoc- 
ulation route (Table 2); however, the mean time to death 
was longer (more than a day) than that associated with 
0P/1370/83 infection, which also was uniformly fatal. 
Similarly, EP93-M1 was lethal in all chickens after intra- 
muscular inoculation and in 33% after intranasal/oral in- 
oculation, whereas the parent virus did not kill any chick- 
ens. Virus was isolated from all organs tested among 
TABLE 2 
VIRULENCE QF THE MUTANT VIRUSES JN CHICKENS 
Route of inoculation a [sick/dead/total No. 
(mean death time _+ SD)] 
Virus i.m, i.n./o. 
O P/1/83 0/1/13 2/0/13 
CP/1/83-M1 13/13/13 (4.2 +_ 1.0) 13/13/13 (6.2 +_ 1.7) 
CP/1370/83 13/13/13 (2.5 + 0.3) 13/13/13 (3.4 + 0.5) 
EP93 1/0/12 0/0/14 
EP93-M1 10/10/10 (5,1 m 1.8) 8/4/12 
Five-day-old specific-pathogen-free chicks were inoculated intra- 
muscularly (i.m.) or intranasally/orally (i.n./o.) with each virus (107.0 
EIDso) and observed for 10 days. Mean death times (days) with standard 
deviations (SD) are presented for the viruses that killed all chickens. 
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TABLE 3 
REPLICATION OF MUTANT VIRUSES IN CHICKEN ORGANS AFTER INTRANASAL/ORAL INOCULATION a 
Organs 
Virus Brain Trachea Lung Liver K idney Pancreas Thymus Spleen Bursa Jejunum Colon 
CP/1/83 - -  3.0 . . . . . . . . .  
CP/1/83-M1 6.0 5.0 7.0 5.0 >~7.5 ~7.5 6.0 5.0 5.0 6.0 6.0 
CP/1370/83 >~7.5 6.0 >17,5 6.0 >~7.5 1>7,5 6.0 6.0 6.0 >/7.5 6.5 
EP93 . . . . . . . . . . .  
EP93-M1 4.5 5.0 6.5 4.5 >~7.5 >~7.5 5.0 3.5 5.5 4,5 >/7.5 
a Organs were collected from three infected chickens 3 days postinoculation, pooled, and homogenated for virus titration. Virus titers are shown 
as Iog~oEIDso/g. Dashes indicate titers of <102SEIDso/g. 
chickens inoculated with either mutant (Table 3), indicat- 
ing that tissue tropism was altered by the mutations and 
that the HAs of the mutants were activated by proteases 
in all organs tested. 
In the present study, 14-day-old eggs readily selected 
virulent mutants from the avirulent 1983 Pennsylvania 
virus (CP/1/83) after three passages, as reported by 
Brugh and Beck (6). This finding stands in contrast to 
observation, in which successive passages of CP/1/83 
in chickens, as well as 10- to 11-day-old eggs, which are 
used routinely for virus propagation, failed to produce 
virulent mutants (10, this study). The two mutants we 
describe, CP/1/83-M1 and -M2, showed changes in the 
HA gene resulting in loss of glycosylation at Ash-11, but 
no alterations, at the cleavage site, consistent with the 
mutation characterizing the virulent isolate from the 1983 
outbreak (4). These observations are contrary to those 
of Ohuchi et aL (5), whose virulent mutants of 0P/1/83, 
selected through successive passages in trypsin-free 
CEF culture, had increased numbers of basic residues 
at the HA cleavage site without alteration of a glycosyla- 
tion site at Asn-11. Hence, the selective pressures giving 
rise to virulent mutants in 14-day-old eggs appear similar 
to those responsible for the 1983 influenza outbreak. 
If older eggs play a role in selecting virulent viruses 
in nature, how would avirulent viruses be introduced into 
this medium? Although evidence for natural transmission 
of avirulent influenza viruses into eggs is lacking, such 
events may occur in rare instances, as demonstrated for 
virulent viruses (3). Whatever the mode of introduction 
(through a cracked egg shell or transmission in blood), 
the entry of the virus or the initiation of replication would 
have to coincide precisely with aging conditions in the 
egg to allow the production of mutants. Without new 
information from studies of egg infection by avirulent vi- 
ruses, the role of older eggs in the generation of patho- 
genic avian viruses in nature will be difficult to resolve. 
Sequencing studies of virulent viruses selected from 
0P/1/83 during passage in older eggs revealed only a 
single mutation in the HA gene (CP/1/83-M1). Since the 
HA gene was a critical determinant of virulence in the 
virus responsible for the 1983 outbreak (11), only a single 
HA mutation appears required for conversion to a virulent 
phenotype. Other HA mutations in the 1983 virulent iso- 
late (4), or perhaps as yet unidentified mutations in other 
genes, likely influence the extent of virulence, as was 
indicated by the greater virulence of the natural isolate, 
CP/1370/83, as compared to CP/1/83-M1, in this study 
(Table 2). 
Using older eggs, we also obtained a virulent mutant 
from the recently isolated avirulent EP93 virus. Analo- 
gous to the CP/1/83 virus, it was characterized by a sin- 
gle amino acid change at the glycosylation site in its HA, 
resulting in the acquisition of a highly cleavable HA and 
a virulent phenotype. These observations indicate that 
avirulent viruses with the potential for virulence are cur- 
rently circulating in nature. To guard against future avian 
influenza outbreaks, we recommend the eradication of 
such viruses as soon as they appear in poultry. 
Previous studies with HA cleavage mutants indicate 
that the cleavability of this molecule is determined essen- 
tially by the amino acid sequences immediately upstream 
of the cleavage site and is influenced by the nearby 
carbohydrate side chain at Ash-11, which affects acces- 
sibility of the cleavage enzymes (5, 9, 12- 14). From these 
results, the sequence requirement for HA cleavage by 
intracellular proteases is thought to be R/K-X-R/K-R (X, 
nonbasic residue) in the absence of a nearby oligosac- 
charide side chain. In its presence, at least two amino 
acid insertions, X-X-R/K-X-R/K-R, or alteration of the con- 
served proline at -6  or glutamine at -5  position [i.e., 
B(X)-X(B)-R/K-X-R/K-R (B, basic residue)], is required. Of 
these motifs, the basic residues at the second position 
from the carboxyl terminus of the HA1 appear not to be 
strictly required for recognition by cleavage enzymes (9, 
12, 15, this study). We now propose thatthe R-K-T-R motif 
in the absence of a nearby oligosaccharide side chain 
should also be included as part of the virulent phenotype, 
and speculate that this motif with either two amino acid 
insertions or an additional basic residue may serve as 
a virulent-type sequence in the presence of an oligosac- 
charide chain. The cleavage site sequence (R-K-R-K-T- 
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R) of a recently isolated virulent virus A/turkey/England/ 
90-62/91 (H5N1) (8) supports this idea. 
A subtilisin-like endoprotease, furin, which appears to 
be responsible for virulent-type HA cleavage in vivo (16, 
17), recognizes the R-X-X-R motif as a minimal sequence 
requirement (18). HA cleavage of H7 laboratory mutants 
with R-T-A-R sequence by furin supports this notion (15). 
Typical H5 avirulent viruses contain the R-E-T-R se- 
quence at the HA cleavage site. Whether the HA with 
this sequence in the absence of a nearby oligosaccha- 
ride chain is cleaved by furin remains unknown. We were 
not able to select any virulent viruses with cleavable HAs 
from TM81 and R(MO-4), both of which have R-E-T-R, 
suggesting that multiple mutations are required for the 
acquisition of high HA cleavability by these HAs. Al- 
though this motif matches the minimal sequence require- 
ment for furin, the electrostatic environment may not be 
suitable for its recognition because of negatively charged 
glutamic acid at the third position from the carboxyl-ter- 
minus of the HA1. Thus, in natural settings, some avian 
viruses may possess a greater potential for virulence 
than do others. 
Beyond the molecular requirements mentioned above, 
what is the basis for the generation of virulent viruses in 
14-day-old eggs? To become dominant in older eggs, 
virulent viruses must replicate in a manner favoring their 
selection or avirulent viruses must replicate poorly. Dif- 
ferences in anatomical properties, protease proper[ies 
for HA cleavage, or amount of urates between older and 
younger eggs offer plausible explanations, although evi- 
dence for their role as selective factors is lacking (19). 
When we measured the protease activity of allantoic flu- 
ids in 10-and 14-day-old eggs using a synthetic substrate 
for blood-clotting factor Xa, a putative cleavage enzyme 
of avirulent-type HAs (20), the older eggs possessed 
stronger activity. Consistent with this result, HA cleavage 
activity was higher by RIP analysis in allantoic fluids from 
14-day-old eggs compared to 10-day-old eggs (data not 
shown). Thus, the selection of virulent viruses in older 
eggs does not involve reduced activity of cleavage en- 
zyme(s) for avirulent virus HAs, which would lead to a 
replicative disadvantage of avirulent viruses. In separate 
experiments, HA degradation in the allantoic fluid of older 
eggs was observed, but not in that of younger eggs, after 
an extended period of incubation. This finding raised a 
possibility that virulent viruses, which can invade and 
replicate in the inner layers of the chorioallantoic mem- 
brane and embryo (21), may escape degradation by pro- 
teases in the allantoic fluid, thus gaining a replicative 
advantage in older eggs. Whether a similar process oc- 
curs in nature remains in question. 
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